Mark Andrews Partners with Genentech to Raise Awareness for Diabetic Macular Edema.
Jun 30, 2026
Contract Type
partnership
South San FranciscoManufacturingBiotechnologyHealth CareMedicalTherapeuticsresearch
Description
Baltimore Ravens tight end Mark Andrews has announced a partnership with biotech company Genentech to raise awareness of diabetic macular edema (DME). This partnership aims to encourage individuals with diabetes to prioritize their vision health and seek regular screenings.
Company Information
Company
Genentech
Location
1 DNA Way
South San Francisco, California, United States
About
Genentech is passionate about finding solutions for some of the world’s most difficult-to-treat conditions, using cutting-edge science to create and deliver innovative medicines worldwide. With a belief that science is personal, Genentech is dedicated to making a difference in the lives of millions and invites those who share this mission to explore career opportunities at gene.com/careers.